Reference 2018-19

REF:            2018-19      

Subject:        Intra-Vitreal Injections/Implants    

 

 

Request:

Within your trust how many intra-vitreal injections/implants have been used in the latest 4 months, if possible between September to December 2017.

If your trust is able to identify injections/implants by eye conditions please split by the drug used [ranibizumab, bevacizumab, aflibercept, Fluocinolone and Dexamethasone].

 

 

Response:

We are unable to provide figures by disease state only total numbers for each drug.

 

The table below shows total numbers used between September and December 2017.

  Lucentis (ranibizumab) Injections Avastin (bevacizumab) Injections Eylea (aflibercept) Injections Illuvien (Fluocinolone) Impants Ozudex (Dexamethasone) Implants
Total  855 920   0 20